# Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

> **NCT01994265** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 200 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Dabigatran

## Key facts

- **NCT ID:** NCT01994265
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-07
- **Primary completion:** 2021-03-09
- **Final completion:** 2021-03-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994265, "Cognitive Impairment Related to Atrial Fibrillation Prevention Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01994265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*